KONEXChemicals217910

SJ-Chem

₩247▼ 14.83%2026-11-18 close
Market Cap
₩3.5B
Turnover
₩49,967
Volume
202 shares
Shares out.
14M
PER
—
PBR
—
EPS
—
Dividend Yield
—

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-11-18 close

01

Report overview

Small operating profit, thin capital

SJ-Chem posted an operating profit from its water-treatment coagulant business, but its net loss and capital erosion remain the central issues in its financial structure.

  1. 1

    On a separate basis for fiscal 2025, operating profit stayed positive at KRW 1,001 million, while net loss reached KRW 1,679 million.

  2. 2

    Total equity of KRW 918 million falls below paid-in capital of KRW 1,399 million, which qualifies as capital erosion.

  3. 3

    Recycled PP moved from entry into automotive PCR PP in August 2023 to testing and delivery with automakers by March 2024.

  4. 4

    The share price moved from KRW 322 on March 27, 2026 to KRW 309 as of November 11, 2026 (-2.52% on the day), with a market capitalization of KRW 4.3 billion.

  5. 5

    Across the chemicals and materials sector, weaker core profitability from Chinese oversupply and a slowdown in battery materials is prompting a push into semiconductor materials.

02

Business structure

SJ-Chem was founded in 2003 and listed on KONEX in 2018 as a manufacturer of basic inorganic chemicals. Its core businesses are water-treatment coagulants and recycled polypropylene (PP), and reports indicate coagulants account for the larger share of sales.

The company produces aluminum sulfate and sodium aluminate, inorganic coagulants that remove pollutants from wastewater and raw water sources. According to the WISEreport company monitor, its aluminum sulfate market share is listed at 5.00%.

The company cites its aluminum compound patented technology as the basis for competitiveness in responding to tighter total phosphorus regulation. Its recycled PP business began in October 2022 with entry into post-consumer recycled (PCR) compound resin.

In August 2023 it entered automotive PCR PP tied to the EU End-of-Life Vehicles Directive, and in March 2024 it began testing and supplying German and domestic automakers. Its history also records the purchase of a 17,923㎡ factory site in the Tancheon industrial complex.

In competition, coagulants are compared mainly with specialized mid-sized producers rather than large chemical groups, while automotive PCR PP is at an early stage against established automotive materials suppliers.

03

Recent trends

At the annual general meeting on March 27, 2026, shareholders approved the financial statements for the 23rd fiscal term, the re-appointment of the auditor, a director compensation cap of KRW 700 million, and an auditor compensation cap of KRW 100 million.

Recent press coverage reports that separate-basis revenue for the 23rd term was KRW 10,322 million, operating profit was KRW 1,001 million, and net loss was KRW 1,679 million.

The same filing data lists earnings per share as a loss, total assets at KRW 14,364 million, total liabilities at KRW 13,446 million, and total equity at KRW 918 million.

The WISEreport company monitor describes fiscal 2025 separate revenue as up 12.8% year on year and the net loss as narrowed by 35.7%, yet it records operating profit as down 8.6%.

The same commentary says profitability improved through cost reduction and expense control but also states that total sales declined, so its description of the revenue trend is internally inconsistent. R&D spending in 2025 was KRW 389 million, or 3.77% of sales.

A voluntary disclosure of other material management matters was filed on March 18, 2026, a corrected material matters report on the asset disposal decision followed on March 25, and the audit report was submitted on March 26. The share price stood at KRW 322 at 4:10 p.m. on March 27, 2026, down 0.62% on the day.

As of November 11, 2026, the current price is KRW 309 (-2.52% on the day), and daily trading value was KRW 917,925, below KRW 1 million, indicating very thin trading.

04

Outlook

The coagulant business is supported by demand from tighter total phosphorus regulation, and whether this demand translates into revenue recovery is the first point to track. Recycled PP is still at an early stage, in testing and initial delivery to automotive customers, so its contribution to sales remains limited.

Because sources describe the 2025 revenue trend differently, how the next periodic report characterizes sales is an important checkpoint. Whether the net loss persists despite operating profit depends on changes in non-operating items and income taxes.

Ending capital erosion, where total equity sits below paid-in capital, would require accumulated earnings or new equity. Oversupply across the broader chemicals and materials sector is an additional background factor.

An industry participant has said that new materials businesses require at least five years of resource commitment to take hold. With a market capitalization of KRW 4.3 billion and daily trading value below KRW 1 million, price signals are limited, which matters when reading the data.

The asset disposal decision corrected in March 2026 is tied to changes in asset composition and will likely be clarified in later filings.

05

Bull factors

Operating profit base in coagulants

Keeping operating profit positive in the coagulant business is presented as a strength of the core franchise. The WISEreport company monitor attributes improved profitability to cost reduction and expense control.

Its aluminum sulfate market share is listed at 5.00%, and rising demand for sodium aluminate is cited as supporting coagulant sales.

Regulation paired with patented technology

Tighter total phosphorus regulation is presented as a demand driver for coagulants. The company says its aluminum compound patents underpin its technological competitiveness. The government's smart water industry strategy is also cited as a backdrop to the business.

Entry of recycled PP into automotive materials

In August 2023 the company entered automotive PCR PP linked to the EU End-of-Life Vehicles Directive. In March 2024 it began testing and supply with German and domestic automakers. If recycled PP expands in automotive materials, it would form a second business axis beyond water treatment.

06

Bear factors

Net loss and capital erosion

Separate-basis net loss for fiscal 2025 was KRW 1,679 million, with earnings per share also listed as a loss. Remaining in net loss despite operating profit adds to financial strain.

Liability-heavy structure with thin equity

Total liabilities of KRW 13,446 million account for most of total assets of KRW 14,364 million. With thin equity, financing facility investment from external sources carries a heavier burden. The asset disposal decision corrected in March 2026 is linked to changes in asset composition.

Conflicting sales descriptions and low liquidity

The WISEreport company monitor describes fiscal 2025 separate revenue as up 12.8%, yet also states that total sales declined, so the descriptions conflict. With a market capitalization of KRW 4.3 billion and daily trading value of KRW 917,925, liquidity is extremely low. The share price has moved from KRW 322 on March 27, 2026 to KRW 309.

07

Risk factors

Macro

Across the chemicals and materials sector, existing profitability has weakened under Chinese oversupply and a slowdown in battery materials. This could indirectly affect pricing and demand for coagulants and recycled PP.

As the industry rushes into new materials such as semiconductors, the competitive environment is shifting as well.

Regulatory and commercialization

Tighter total phosphorus regulation is a demand driver, but the pace of demand depends on the regulatory level and timing. The automotive contribution from recycled PP is still at the testing and initial delivery stage.

Establishing new materials businesses requires long-term resource commitment, as an industry participant has noted.

Financial and liquidity

Capital erosion and a high liability ratio leave limited financial buffers. With a market capitalization of KRW 4.3 billion and daily trading value below KRW 1 million on KONEX, both price formation and fundraising may be constrained. If the net loss continues, improvement in the capital structure becomes more important.

08

Overall view

SJ-Chem is a KONEX-listed chemical company whose core businesses are water-treatment coagulants and recycled PP, and it posted an operating profit on a separate basis for fiscal 2025.

However, a net loss of KRW 1,679 million and total equity of KRW 918 million, below paid-in capital, are the key weaknesses in its financial structure. On the positive side, demand for coagulants tied to total phosphorus regulation and the entry of recycled PP into automotive materials are cited.

On the negative side, capital erosion, a liability-heavy asset structure, conflicting sales descriptions, and low trading liquidity are raised together. The current price of KRW 309 and market capitalization of KRW 4.3 billion as of November 11, 2026 are reference figures for information purposes.

Whether the business direction and financial structure improve will be clarified in subsequent periodic reports and audit-related disclosures.

09

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 6 more articles and sources
  1. comp.wisereport.co.kr
  2. comp.wisereport.co.kr
  3. m.news.nate.com
  4. m.irgo.co.kr
  5. news1.kr
  6. m.jobkorea.co.kr

Report written 2026-11-11 · Data as of 2026-11-10

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis